Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Feb 2026.
- Largest single sale: $438K (563 shares) of Regeneron Pharmaceuticals on Feb 9, 2026. Filing
- Last sale before this period: Aug 7, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | SVP Controller | Feb 8, 2024 | Feb 11, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 9, 2026, Regeneron Pharmaceuticals: sold 2,036 shares for $1.6M, under a disclosed plan; 1,000 shares acquired by exercising options. 1 filing: 1
- Dec 8, 2025, Regeneron Pharmaceuticals: 989 shares withheld by the company for taxes. 1 filing: 1
- Dec 5, 2025, Regeneron Pharmaceuticals: 2,064 shares awarded. 1 filing: 1
- Nov 7, 2025, Regeneron Pharmaceuticals: sold 431 shares for $281K, no plan disclosed. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.